Low versus standard dose intravenous alteplase in acute ischemic stroke
<h4>Background</h4> <p>Thrombolytic therapy for acute ischemic stroke with lower than standard dose of intravenous alteplase may improve recovery with reduced risk of intracerebral hemorrhage (ICH).</p> <h4>Methods</h4> <p>Using a 2-by-2 quasi-factorial open...
Main Authors: | Woodward, M, Anderson, C, Robinson, T, Lindley, R, Arima, H, Lavados, P, Lee, T, Broderick, J, Chen, X, Chen, G, Sharma, V, Kim, J, Thang, N, Cao, Y, Parsons, M, Levi, C, Huang, Y, Olavarria, V, Demchuk, A, Bath, P, Donnan, G, Martins, S, Pontes-Neto, O, Silva, F, Ricci, S, Roffe, C, Pandian, J, Billot, L, Li, Q, Wang, X, Wang, J, Chalmers, J |
---|---|
Format: | Journal article |
Published: |
Massachusetts Medical Society
2016
|
Similar Items
-
Low- versus standard-dose alteplase in patients on prior antiplatelet therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
by: Robinson, T, et al.
Published: (2017) -
Who will benefit more from low-dose alteplase in acute ischemic stroke?
by: Wang, X, et al.
Published: (2019) -
Influence of renal impairment on outcome for thrombolysis-treated acute ischemic stroke: ENCHANTED post-hoc analysis
by: Carr, S, et al.
Published: (2017) -
Reactions to alteplase in patients with acute thrombotic stroke - Reply
by: Hill, MD, et al.
Published: (2000) -
Sex differences in treatment and outcome after stroke: pooled analysis including 19,000 participants
by: Carcel, C, et al.
Published: (2019)